ALIVAMAB

Serial Number 97079579
606

Registration Progress

Application Filed
Oct 18, 2021
Under Examination
Oct 25, 2022
Approved for Publication
Aug 30, 2022
Published for Opposition
Aug 30, 2022
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Feb 01, 2026 11 days
Revival assistance for abandoned trademark

Trademark Image

ALIVAMAB

Basic Information

Serial Number
97079579
Filing Date
October 18, 2021
Published for Opposition
August 30, 2022
Abandonment Date
December 1, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 1, 2025
Classes
001 005

Rights Holder

Ablexis, LLC

16
Address
Suite 115
10581 Roselle Street
San Diego, CA 92121

Ownership History

Ablexis, LLC

Original Applicant
16
San Diego, CA

Ablexis, LLC

Owner at Publication
16
San Diego, CA

Legal Representation

Attorney
Jason S. Ingerman

USPTO Deadlines

Next Deadline
11 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
February 01, 2026

Application History

35 events
Date Code Type Description Documents
Dec 1, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 1, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jul 26, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 25, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Apr 10, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Jul 25, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 11, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 23, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 23, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Oct 23, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Oct 23, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 20, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 19, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 19, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 19, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 26, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 24, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 24, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 24, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 27, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 25, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 25, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 25, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 25, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 30, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 30, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 10, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 25, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 25, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 25, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 25, 2022 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 25, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 25, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 4, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 21, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Biological preparations for use in industry and science, namely, preparations for antibody development
Class 005
Pharmaceuticals, namely, preparations for monoclonal antibody and monoclonal antibody-derivative development

Classification

International Classes
001 005